DANIEL NARDI: Open Payments
NPI 1255971883 · FAYETTEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$984 in 39 payments from 19 companies in 2025. Trend: 2023 $513 · 2024 $440 · 2025 $984
Food & beverage: $820Education: $164
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $190 |
| Regeneron Healthcare Solutions, Inc. | 2 | $125 |
| GENZYME CORPORATION | 4 | $99 |
| GlaxoSmithKline, LLC. | 4 | $93 |
| Actelion Pharmaceuticals US, Inc. | 2 | $89 |
| Verona Pharma, Inc. | 2 | $54 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $44 |
| United Therapeutics Corporation | 1 | $34 |
| Lilly USA, LLC | 2 | $32 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
Products named: DUPIXENT, OPSUMIT, AIRSUPRA, NUCALA, Ohtuvayre, BREZTRI, LUMRYZ, Tyvaso.
Industry payments across NC — which companies pay providers there.
